Key result
In silico models incorporating genomic differences and sex steroid hormones predicted longer female cardiac action potential durations and higher vulnerability to reentrant arrhythmias, particularly during the late follicular phase.
Why the study?
How do genomic differences and sex steroid hormones contribute to sex-based differences in susceptibility to ventricular tachyarrhythmias?
How do genomic differences and sex steroid hormones contribute to sex-based differences in susceptibility to ventricular tachyarrhythmias?
Answers are grounded in this paper and cite their sources.
Computational modeling reveals that sex-specific genomic differences in ion channel expression and sex steroid hormones mechanistically explain the higher risk of Torsades de Pointes in females.
Sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias likely result from the emergent effects of multiple intersecting processes that fundamentally differ in male and female hearts. Included are measured differences in the genes encoding key cardiac ion channels and effects of sex steroid hormones to acutely modify electrical activity. At the genome-scale, human females have recently been shown to have lower expression of genes encoding key cardiac repolarizing potassium currents and connexin43, the primary ventricular gap-junction subunit. Human males and females also have distinct sex steroid hormones. Here, we developed mathematical models for male and female ventricular human heart cells by incorporating experimentally determined genomic differences and effects of sex steroid hormones into the O'Hara-Rudy model. These "male" and "female" model cells and tissues then were used to predict how various sex-based differences underlie arrhythmia risk. Genomic-based differences in ion channel expression were alone sufficient to determine longer female cardiac action potential durations (APD) in both epicardial and endocardial cells compared to males. Subsequent addition of sex steroid hormones exacerbated these differences, as testosterone further shortened APDs, while estrogen and progesterone application resulted in disparate effects on APDs. Our results indicate that incorporation of experimentally determined genomic differences from human hearts in conjunction with sex steroid hormones are consistent with clinically observed differences in QT interval, T-wave shape and morphology, and critically, in the higher vulnerability of adult human females to Torsades de Pointes type arrhythmias. The model suggests that female susceptibility to alternans stems from longer female action potentials, while reentrant arrhythmia derives largely from sex-based differences in conduction play an important role in arrhythmia vulnerability.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2012) studied Cardiac ventricular tachyarrhythmias. Sex-based genomic differences and sex steroid hormones vs. Male models and no hormone conditions was evaluated on Action potential duration (APD) and susceptibility to reentrant arrhythmias. In silico models incorporating genomic differences and sex steroid hormones predicted longer female cardiac action potential durations and higher vulnerability to reentrant arrhythmias, particularly during the late follicular phase.
Synapse has enriched 10 related papers. Consider them for comparative context: